| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-13 11:41:48 UTC |
|---|
| Update Date | 2022-03-07 02:57:12 UTC |
|---|
| HMDB ID | HMDB0041834 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Benzbromarone |
|---|
| Description | Benzbromarone (INN) is a uricosuric agent used in the treatment of gout, especially when allopurinol, a first-line treatment, fails or produces intolerable adverse effects. It is structurally related to the antiarrhythmic amiodarone. Benzbromarone is a very potent inhibitor of CYP2C9. Several analogues of the drug have been developed as CYP2C9 and CYP2C19 inhibitors for use in research. |
|---|
| Structure | CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=CC=CC=C2O1 InChI=1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 2-Ethyl-3-(3,5-dibrom-4-hydroxybenzoyl)benzofuran | ChEBI | | 3,5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone | ChEBI | | Uroleap | ChEBI | | (3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone | HMDB | | 3, 5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone | HMDB | | Benzbromaron | HMDB | | Benzbromarone(usan) | HMDB | | Desuric | HMDB | | Exurate | HMDB | | Hipurik | HMDB | | Ketone, 3,5-dibromo-4-hydroxyphenyl 2-ethyl-3-benzofuranyl | HMDB | | L 2214-Labaz | HMDB | | Minuric | HMDB | | Normurat | HMDB | | Uricovac | HMDB | | Urinorm | HMDB | | AL, benzbromaron | HMDB | | Aliud brand OF benzbromarone | HMDB | | Benzbromaron al | HMDB | | Besuric | HMDB | | Sanfer brand OF benzbromarone | HMDB | | Ratiopharm brand OF benzbromarone | HMDB | | Acifugan | HMDB | | Benzbromaronratiopharm | HMDB | | Heumann brand OF benzbromarone | HMDB | | Benzbromaron ratiopharm | HMDB | | Benzbromarone aliud brand | HMDB | | Benzbromarone heumann brand | HMDB | | Benzbromarone sanfer brand | HMDB | | Benzbromarone ratiopharm brand | HMDB | | Narcaricin | HMDB | | Sanofi winthrop brand OF benzbromarone | HMDB | | Benzbromaron-ratiopharm | HMDB |
|
|---|
| Chemical Formula | C17H12Br2O3 |
|---|
| Average Molecular Weight | 424.083 |
|---|
| Monoisotopic Molecular Weight | 421.915319544 |
|---|
| IUPAC Name | 2,6-dibromo-4-(2-ethyl-1-benzofuran-3-carbonyl)phenol |
|---|
| Traditional Name | benzbromarone |
|---|
| CAS Registry Number | 3562-84-3 |
|---|
| SMILES | CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=CC=CC=C2O1 |
|---|
| InChI Identifier | InChI=1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3 |
|---|
| InChI Key | WHQCHUCQKNIQEC-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as aryl-phenylketones. These are aromatic compounds containing a ketone substituted by one aryl group, and a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbonyl compounds |
|---|
| Direct Parent | Aryl-phenylketones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aryl-phenylketone
- Benzofuran
- 3-aroylfuran
- Benzoyl
- 2-bromophenol
- 2-halophenol
- Phenol
- Bromobenzene
- Halobenzene
- Aryl bromide
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Heteroaromatic compound
- Furan
- Oxacycle
- Organoheterocyclic compound
- Organic oxide
- Hydrocarbon derivative
- Organobromide
- Organohalogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 151 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 8.62 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 19.8816 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 0.77 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2721.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 678.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 260.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 416.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 430.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 758.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 869.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 77.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1649.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 708.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1787.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 649.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 521.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 461.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 431.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 22.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Benzbromarone GC-MS (Non-derivatized) - 70eV, Positive | splash10-05i1-4832900000-7ab986576555401c2682 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Benzbromarone GC-MS (1 TMS) - 70eV, Positive | splash10-00e9-9503700000-00cd0af3f4c2c3b65960 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Benzbromarone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzbromarone 35V, Negative-QTOF | splash10-00di-0000900000-94d07af34f38fb48d939 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzbromarone 10V, Positive-QTOF | splash10-00di-0120900000-fc249a1eb88559bbcbb1 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzbromarone 20V, Positive-QTOF | splash10-00b9-0591400000-e59e173f15483ef2be8f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzbromarone 40V, Positive-QTOF | splash10-004j-1290000000-c6ab434e069c23434652 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzbromarone 10V, Negative-QTOF | splash10-00di-0000900000-65ce336d84ac3bc1b6cf | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzbromarone 20V, Negative-QTOF | splash10-00di-0332900000-1e5e89c78006263a0948 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzbromarone 40V, Negative-QTOF | splash10-0005-2931000000-017d942ea5bfdf5d7a10 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzbromarone 10V, Negative-QTOF | splash10-00di-0000900000-dacd5da7c3b80a31dd02 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzbromarone 20V, Negative-QTOF | splash10-00di-4000900000-8beeba5ecf13d3cdd46c | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzbromarone 40V, Negative-QTOF | splash10-004i-9000000000-abb69a363cc923ebb9e1 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzbromarone 10V, Positive-QTOF | splash10-00di-0000900000-2199f895a98ec54296c3 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzbromarone 20V, Positive-QTOF | splash10-00fr-0180900000-6045f757598f9ed9a40f | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzbromarone 40V, Positive-QTOF | splash10-004l-1590000000-09a3248599d038d0c11b | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|